Infection disease

Infectious diseases, caused by pathogens such as bacteria, viruses, fungi, and parasites, pose significant global health challenges. Biotech companies play a crucial role by developing novel vaccines, antiviral therapies, and antimicrobial agents to combat these diseases. Medtech firms contribute through rapid diagnostic tools and innovative medical devices that enhance disease detection and management. Pharma companies focus on producing and distributing a wide range of therapeutics, including antibiotics and antiviral drugs. Due to the high costs and public health implications, cost-effectiveness analysis and health economics are vital to demonstrate the value and efficiency of new treatments. These analyses aid in payer negotiations, ensuring that life-saving interventions are affordable and accessible, and support the adoption and reimbursement of innovative infectious disease solutions.